Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 2 |
2018 | 2 |
2019 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Advances in ovarian cancer therapy.
Cancer Chemother Pharmacol. 2018 Jan;81(1):17-38. doi: 10.1007/s00280-017-3501-8. Epub 2017 Dec 16.
Cancer Chemother Pharmacol. 2018.
PMID: 29249039
Free PMC article.
Review.
Characteristics of in Vivo Model Systems for Ovarian Cancer Studies.
Tudrej P, Kujawa KA, Cortez AJ, Lisowska KM.
Tudrej P, et al.
Diagnostics (Basel). 2019 Sep 14;9(3):120. doi: 10.3390/diagnostics9030120.
Diagnostics (Basel). 2019.
PMID: 31540126
Free PMC article.
Review.
Item in Clipboard
Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8.
Tudrej P, Olbryt M, Zembala-Nożyńska E, Kujawa KA, Cortez AJ, Fiszer-Kierzkowska A, Pigłowski W, Nikiel B, Głowala-Kosińska M, Bartkowska-Chrobok A, Smagur A, Fidyk W, Lisowska KM.
Tudrej P, et al.
Int J Mol Sci. 2018 Jul 17;19(7):2080. doi: 10.3390/ijms19072080.
Int J Mol Sci. 2018.
PMID: 30018258
Free PMC article.
Item in Clipboard
Liquid biopsy utilizing miRNA in patients with advanced breast cancer treated with cyclin‑dependent kinase 4/6 inhibitors.
Kubeczko M, Tudrej P, Tyszkiewicz T, Krzywon A, Oczko-Wojciechowska M, JarzĄb M.
Kubeczko M, et al. Among authors: tudrej p.
Oncol Lett. 2024 Feb 28;27(4):181. doi: 10.3892/ol.2024.14314. eCollection 2024 Apr.
Oncol Lett. 2024.
PMID: 38464342
Free PMC article.
Item in Clipboard
Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulation.
Olbryt M, Rusin A, Fokt I, Habryka A, Tudrej P, Student S, Sochanik A, Zieliński R, Priebe W.
Olbryt M, et al. Among authors: tudrej p.
Invest New Drugs. 2017 Oct;35(5):545-555. doi: 10.1007/s10637-017-0465-9. Epub 2017 Apr 17.
Invest New Drugs. 2017.
PMID: 28417283
Free PMC article.
Item in Clipboard
Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival.
Lisowska KM, Olbryt M, Student S, Kujawa KA, Cortez AJ, Simek K, Dansonka-Mieszkowska A, Rzepecka IK, Tudrej P, Kupryjańczyk J.
Lisowska KM, et al. Among authors: tudrej p.
J Cancer Res Clin Oncol. 2016 Jun;142(6):1239-52. doi: 10.1007/s00432-016-2147-y. Epub 2016 Mar 30.
J Cancer Res Clin Oncol. 2016.
PMID: 27028324
Free PMC article.
Item in Clipboard
Cite
Cite